Explore evidence

11.74 USD_per_client_monthThe estimated financial cost per client-month on PrEP was $11.74 USD for non-subsidized delivery.

KenyaVIH/sidapublished 2025BMC health services researchPubMeddocument of 13 observations

69 %Among clients eligible to continue PrEP at the pharmacy, 69% (479/691) refilled at least once.

KenyaVIH/sidaobserved February to July 2022published 2025BMC health services researchPubMeddocument of 13 observations

2.6 timesAmong female sex workers in Kenya, those in the HIV self-testing intervention group were 2.6 times more likely to test for HIV within ≤2 months post-announcement than those in the standard of care group.

KenyaVIH/sidapublished 2022Frontiers in public healthPubMeddocument of 6 observations

59 %Over half of women living with HIV in the study reported that their last pregnancy was unintended, at 59%.

KenyaVIH/sidaobserved 2015 to 2017published 2021BMC women's healthPubMeddocument of 7 observations

2.07 aRRWomen who reported alcohol use had an adjusted risk ratio of 2.07 for HIV seroconversion.

KenyaVIH/sidapublished 2021PloS onePubMeddocument of 16 observations

47 %The proportion of people living with HIV that were virally suppressed increased from 7–14% to 39–55% among people who inject drugs in Nairobi and Coastal Kenya over 2012–2015.

KenyaVIH/sidaobserved 2012-2015published 2025The International journal on drug policyPubMeddocument of 10 observations

The majority of pre-treatment HIV drug resistance transmission clusters in Kenya had a reproductive number R₀ ≥ 1.0, indicating ongoing transmission.

KenyaVIH/sidapublished 2024The Journal of antimicrobial chemotherapyPubMeddocument of 7 observations

90 %Of the 16.6 million children orphaned due to HIV/AIDS, 90% live in sub-Saharan Africa.

KenyaVIH/sidapublished 2021JAMA network openPubMeddocument of 15 observations

1.6 %In Teso, Western Kenya, HIV-1 inter-subtype recombinants A1-A2, A1-C, BC, and BD each accounted for 1 out of 63 sequenced samples (1.6%).

KenyaVIH/sidaobserved 2019published 2021The Pan African medical journalPubMeddocument of 7 observations

13.9 %Among HIV-infected adults initiating cART in Kenya, 13.9% had initial virologic non-suppression (VnS).

KenyaVIH/sidapublished 2022PloS onePubMeddocument of 4 observations

40 %Among men who have sex with men living with HIV in Kenya, 40.0% of those who solely met partners via physical sites (PMSM) were on antiretroviral treatment.

KenyaVIH/sidaobserved 2019published 2020Journal of the International AIDS SocietyPubMeddocument of 12 observations

84.4 %Viral suppression 6 months postintervention was 84.4% among patients receiving provider-patient communication (PPC) training plus enhanced patient care (EPC).

KenyaVIH/sidapublished 2022Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 5 observations

Outpatient departments in sub-Saharan Africa diagnose a high proportion of new HIV infections.

KenyaVIH/sidapublished 2024AIDS (London, England)PubMeddocument of 18 observations

0 %Fingerprint technology had a false acceptance rate of 0% for unique patient matching and identification in an HIV care and treatment facility in Western Kenya.

KenyaVIH/sidapublished 2021Journal of medical Internet researchPubMeddocument of 11 observations

39.8 hoursIn scenario 1, the average turnaround time (TAT) for HIV viral load monitoring was 39.8 hours.

KenyaVIH/sidapublished 2024Health policy and planningPubMeddocument of 15 observations

90 %Among smear-positive pulmonary tuberculosis/HIV co-infected patients in Kenya between 2012 and 2015, 90% had a treatment outcome of cured.

Kenyatuberculose · VIH/sidaobserved 2012-2015published 2020PloS onePubMeddocument of 6 observations

10.1 %From May 2018 to March 2020, 772 out of 7614 male partners named by 2534 female index clients tested positive for HIV, representing a positivity rate of 10.1%.

KenyaVIH/sidaobserved May 2018 to March 2020published 2025Sexually transmitted diseasesPubMeddocument of 9 observations

Most factors in Western and South-East Kenya recorded a high infection prevalence of both HIV and malaria.

Kenyapaludisme · VIH/sidapublished 2021BMJ global healtheurope_pmcdocument of 3 observations

25.8 %The proportion of patients linked back to treatment was 25.8% in clinics with electronic health records only.

KenyaVIH/sidaobserved between Sept 1, 2012 and Jan 31, 2014published 2021BMC medical informatics and decision makingPubMeddocument of 5 observations

704 casesIn a pooled cohort of 117,114 individuals with baseline HIV negative test results in rural Uganda and Kenya, 704 seroconverted within 3 years.

KenyaVIH/sidapublished 2021PloS onePubMeddocument of 16 observations

77 %Most participants (77%) were willing to ask their sex partner(s) to self-test before having sex.

KenyaVIH/sidapublished 2023AIDS carePubMeddocument of 5 observations

94 %A majority of surveyed PrEP clients (269 out of 285, or 94%) reported HIV risk.

KenyaVIH/sidapublished 2024Journal of the International Association of Providers of AIDS CarePubMeddocument of 5 observations

33.3 %Offering structured PrEP and PEP choice including long-acting cabotegravir and enabling risk-informed use could reduce HIV incidence by a third over 10 years.

KenyaVIH/sidaobserved 10 yearspublished 2025The lancet. HIVPubMeddocument of 11 observations

25.3 %In 1990, 25.3% of 1,000-person communities in western Kenya were HIV prevalence outliers.

KenyaVIH/sidaobserved 1990published 2025PLoS computational biologyPubMeddocument of 2 observations

33.3 yearsThe mean age of the 9,026 smear-positive pulmonary tuberculosis/HIV co-infected patients aged 15–49 years in Kenya between 2012 and 2015 was 33.3 years.

Kenyatuberculose · VIH/sidaobserved 2012-2015published 2020PloS onePubMeddocument of 6 observations